Company Overview

Development Stage

About the Company

[Summary] Pioneered a new field in foot-and-mouth disease vaccines

Shenlian Biopharmaceutical (Shanghai) Co., Ltd. (stock code: 688098) was established in June 2001 with a registered capital of 410.64 million RMB. Headquartered in Shanghai Zizhu High-tech Industrial Development Zone, it is a national high-tech enterprise specializing in the R&D, production, and sales of veterinary biological products. The company is a national high-tech enterprise and a Shanghai Municipal Enterprise Technology Center, and has been recognized as a Shanghai Patent Work Pilot Enterprise, one of Shanghai's Top Ten High-tech Independent Innovation Enterprises, a Shanghai Specialized and Sophisticated Enterprise, and one of Minhang District's Top 100 Enterprises.
Shenlian Biopharmaceutical (Shanghai) Co., Ltd. Lanzhou Branch (hereinafter referred to as Lanzhou Company), established in January 2014, covers an area of 13,300 m² and is located in Lanzhou New Area, Lanzhou City, Gansu Province. It serves as an important production base for animal vaccines. The company has built a state-of-the-art foot-and-mouth disease vaccine production workshop, which was the first to pass national biological safety level 3 protection acceptance for major animal diseases and the national GMP dynamic inspection for veterinary drugs.
Shenlian Biopharm is committed to building a high-tech biopharmaceutical company with a mission to "pioneer life science technology and create great achievements for human health," adhering to the philosophy of "innovation leads development, quality builds brand, integrity serves customers, and gathering talent builds the future," providing better products and higher-quality services for China's animal disease prevention and control efforts.
01 Shenlian Strength
- First STAR Market listed company in the animal health industry
- National designated manufacturer of foot-and-mouth disease vaccines
- National high-tech enterprise
- Shanghai specialized and sophisticated enterprise
- Top tier in the foot-and-mouth disease field
- Fully automated animal vaccine production line
- Global pioneer in the development and production of synthetic peptide vaccines for foot-and-mouth disease
02 Strong Scientific Research Capabilities
- Excellent R&D hardware: R&D building covers 9,947 m², with laboratory space of 4,052 m²; nearly 500 R&D equipment units, of which imported equipment accounts for over 80%.
- Outstanding innovation: Composed of academicians, technical experts, and overseas-returned PhDs with extensive industry experience and multidisciplinary backgrounds; master's degree or above accounts for over 60%.
- Four major technology platforms across multiple dimensions: synthetic peptide vaccine technology, inactivated vaccine technology, virus-like particle vaccine technology, and in-vitro diagnostic technology.
- Diversified product layout: with foot-and-mouth disease vaccines as the mainstay, supplemented by other animal vaccines and diagnostic reagents, accelerating product diversification.
03 Leading Production Management
- Leveraging the advantageous resources of Shanghai as an international metropolis, efficiently operating research centers, marketing centers, and management centers.
- High-standard intelligent production workshops + advanced process equipment + P3 laboratory animal facilities.
- Complete quality management system: dual certification of GMP and ISO, establishing a scientific and efficient three-level quality management system.
04 Sales Network Nationwide
- Product sales network covers 30 provinces and cities.
- Top tier in the foot-and-mouth disease field.
- High-quality after-sales service: industry experts, local service expert network, and 1,500 service institutions.
Products on sale: Foot-and-Mouth Disease Type O Synthetic Peptide Vaccine (peptides 2600+2700+2800),
Foot-and-Mouth Disease Type O and A Bivalent Synthetic Peptide Vaccine (peptides 2700+2800+MM13),
Foot-and-Mouth Disease Type O and A Bivalent Inactivated Vaccine (RE-O/MYA98/JSCZ/2013 strain + RE-A/WH/09 strain).
05 Company Benefits
Shenlian Biopharm offers a high-quality and comprehensive welfare system, providing sound guarantees for employees' work and life.
1. Social insurance and housing fund for all employees, with additional commercial supplementary insurance for marketing personnel.
2. Enjoy first-tier city salary and benefits.
3. Comprehensive performance appraisal and bonus system; fair and transparent selection and appointment; as long as you are capable.
4. Comprehensive welfare: living subsidies, holiday benefits, paid annual leave, social insurance and housing fund, tiered commissions, profit sharing, free accommodation (Lanzhou Branch), and special talent apartments (Shanghai HQ).
5. Employee stock ownership plan: employee ownership ratio exceeds 15%, with ongoing incentives to expand coverage.
6. Household registration policy: green channel for settling in the magic city (Shanghai).
We sincerely welcome ambitious individuals to join Shenlian! Let's work together for a promising future!

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

Shenlian Biopharm Financing History (1 rounds)

Manage
IPO上市
Capital Market Favor
Latest Financing Round
  • Date: ?
  • Market:
  • Deal: 上交所

Shenlian Biopharm How Fast Is Hiring Growing? (7 open positions)

Manage
?
Growth Rate
2026 vs 2025
  • 2025: Down 49%
  • 2024: Down 2%
  • 2023: Up 78%
  • 2022: Down 28%
Shenlian Biopharm Year-by-Year Hiring:
* Hiring was generally low during 2020-2022 due to the pandemic
Shenlian Biopharm Campus Recruitment & Advanced Degree Talent Demand
Interns 1 Master's 1
Note: How fast is hiring at Shenlian Biopharmaceutical (Shanghai) Co., Ltd. growing? Shenlian Biopharm2026: 20 openings (down 53%), 2025: 43 openings (down 49%), 2024: 85 openings (down 2%), 2023: 87 openings (up 78%), 2022: 49 openings (down 28%), 2021: 68 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

Shenlian Biopharm Master's Degree Job Demand Analysis

(More)
?
Growth Rate
2026 vs 2025
  • 2025: Down 86%
  • 2024: Up 40%
  • 2023: Down 17%
Shenlian Biopharm Master's Hiring by Year:
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is master's hiring at Shenlian Biopharmaceutical (Shanghai) Co., Ltd. growing? Shenlian BiopharmMaster's recruitment over the years: 2025: 1 openings (down 86%), 2024: 7 openings (up 40%), 2023: 5 openings (down 17%), 2022: 6 openings.

Shenlian Biopharm Doctoral Degree Job Demand Analysis

(More)
N/A
Growth Rate
Shenlian Biopharm Doctoral Hiring by Year: 2024 — 2 fewer jobs than 2023
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is doctoral hiring at Shenlian Biopharmaceutical (Shanghai) Co., Ltd. growing? Shenlian BiopharmDoctorate recruitment over the years: 2024: 6 openings (up 40%), 2023: 8 openings (down 17%), 2022: 9 openings.

Shenlian Biopharm — What Are the Salaries Like? (29 records)

Manage
Shenlian Biopharm Salary Overview
salary range: 3K - 50K, 75.8% of roles pay ¥3-15K
Note: salary statistics are based on 29 salary records from the past year and depend on the job sample. For reference only.
How is the salary at Shenlian Biopharmaceutical (Shanghai) Co., Ltd.?Shenlian Biopharm75.8% of positions earn 3-15K, Undergraduate salary: ¥。销售类 average salary ¥12.4K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of Shenlian Biopharm

(More)
Are salaries high at Shenlian Biopharmaceutical (Shanghai) Co., Ltd.? We provide: 销售,实习生,人力,事务专员,人事,出纳,国际业务,证券,财务,项目经理,业务总监,业务经理,实验员,注册专员,生物技术,申报专员,资源主管,资源经理,资金主管,采购. Click to view detailed salary analysis by job.

Shenlian Biopharm — Fortune 500? (More)

Yes, ranked in 中国高新技术企业慈善公益500强:

Shenlian Biopharm honors, qualifications & industry associations

Shenlian Biopharm Related Industry Tags

Job Category

  • 销售类
    31% of total 31%
  • 在校学生类
    24.1% of total 24.1%
  • 经营管理类
    20.7% of total 20.7%
  • 人力资源类
    17.2% of total 17.2%

Education

  • 本科
    62.1% of total 62.1%
  • 大专
    27.6% of total 27.6%
  • 硕士
    10.3% of total 10.3%

Experience

  • 不限
    41.4% of total 41.4%
  • 1-3年
    37.9% of total 37.9%
  • 3-5年
    10.3% of total 10.3%
  • 5-10年
    10.3% of total 10.3%
View Detailed Analysis

What does Shenlian Biopharmaceutical (Shanghai) Co., Ltd. require? Who is Shenlian Biopharm hiring? Shenlian Biopharm recruitment: 销售类占比最多占31%,其次是在校学生类占24.1%. What education can get in at Shenlian Biopharm? 本科占比最多占62.1%,其次是大专占27.6%. High education required at Shenlian Biopharm? 硕士占10.3%. Work experience required at Shenlian Biopharm? 不限占比最多占41.4%,其次是1-3年占37.9%. Where are the job locations at Shenlian Biopharm? 上海占比最多占100%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 41,064.4万(元)
Legal Representative: 聂东升
Date Established:
Credit Code: 91310000703464848X
Registered Address: 上海市闵行区江川东路48号

Partners & Suppliers

口蹄疫合成肽疫苗供应商,牧原为其核心客户。 Source
合作客户 动保产品
通过洛阳惠中兽药有限公司销售疫苗产品 Source
合作客户 经销商
通过河南省动物疫苗有限公司销售疫苗产品 Source
合作客户 经销商
向大北农销售口蹄疫合成肽疫苗 Source
合作客户 养殖集团客户
向天邦股份销售口蹄疫合成肽疫苗 Source
合作客户 养殖集团客户

People who follow Shenlian Biopharm also follow

Shenlian Biopharm Competitors (Similar Companies)

动物保健 动物健康 兽医 宠物服务
医药 生物制品 生物医药 疫苗
“Bright, Fresh Pleasure”
“奉献精良品质,造就时代品牌”
清洁能源 氢能源 生产 化工能源
口香糖 糖果 进口食品 食品制造
“A leading enterprise in the domestic intelligent controller industry”
证券 证券经纪 证券自营 资产管理
天然橡胶 乳胶 标胶 生产
“To become a world-class chemical new materials company with global ope”
“Technology creates a healthy life”
“Enable the public to get adequate nutrition and rebuild a healthy life”
咨询 医药 医药广告 文化传媒
生物科技/生物工程 生物制品 生物制药 疫苗
乳业 饮品 乳酸菌产品 乳酸菌饮料

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates